docs(evidence): re-verify specimen in-content conversion CTA on current main and live (2026-08-14) - #195
Conversation
…nt main and live (2026-08-14) The review item "[unreviewed-by-opus] The /specimen proof page contains no in-content conversion CTA" is already fixed: PR #155 (b81281f) landed the .band conversion CTA on /specimen on 2026-08-14, superseding the conflict-locked PR #107. This receipt re-verifies the fix against current origin/main (2088b6b) and the live deployment (release 5c6521a): the band CTA to /#start is on source, guarded by check-site.mjs, served live, and covered by the passing test suite. No code change was needed. Co-authored-by: CommandCodeBot <noreply@commandcode.ai>
|
You have reached your Codex usage limits for code reviews. You can see your limits in the Codex usage dashboard. |
There was a problem hiding this comment.
Your trial has ended. Reactivate Greptile to resume code reviews.
|
Warning Review limit reached
Next review available in: 11 minutes Enable usage-based reviews in Billing to review now. Otherwise, wait until the next included review is available. How can I continue?After more reviews become available, a review can be triggered using the To avoid repeated limits, reduce automatic review volume by pausing incremental auto-reviews earlier, using label-based review opt-in, excluding WIP or generated PR titles, or requesting reviews manually when the PR is ready. If your team needs uninterrupted high-volume reviews, an organization admin can enable usage-based reviews. How do review limits work?CodeRabbit enforces per-developer PR review limits for each organization. Most developers receive the normal plan review availability. For paid Pro and Pro+ PR reviews, CodeRabbit uses adaptive limits for sustained high-volume activity. When a developer's recent PR review activity reaches the 95th percentile or higher among CodeRabbit users, additional reviews become available more gradually as earlier reviews age out of the rolling window. Please refer docs for additional details. Review details⚙️ Run configurationConfiguration used: defaults Review profile: CHILL Plan: Free Run ID: 📒 Files selected for processing (2)
Note 🎁 Summarized by CodeRabbit FreeYour organization is on the Free plan. CodeRabbit will generate a high-level summary and a walkthrough for each pull request. For a comprehensive line-by-line review, please upgrade your subscription to CodeRabbit Pro by visiting https://app.coderabbit.ai/login. Comment |
There was a problem hiding this comment.
Your trial has ended. Reactivate Greptile to resume code reviews.
Closeout: review item 94ec723c9e — "[unreviewed-by-opus] The /specimen proof page contains no in-content conversion CTA — the page the homepage routes"
No code change needed. The fix already landed in PR #155 (
b81281f, merged 2026-08-14), which added the in-content.bandconversion CTA to/specimenand superseded the conflict-locked PR #107. This PR records the re-verification of that fix against currentorigin/main(2088b6b) and the live deployment (release5c6521a).Verification
git merge-base --is-ancestor b81281f origin/main→ true (fix on current main)git merge-base --is-ancestor b81281f 5c6521a→ true (fix inside deployed release)public/specimen.htmlcarries the.bandblock with<a class="cta" href="/#start">Request the appraisal</a>and the no-guarantees note (lines 134–139); homepage routes to it via<a href="/specimen">Read the specimen →</a>(index.html line 250)scripts/check-site.mjsstatically guards the band CTA shape, the/#starttarget, the note,.band .ctastyling, and the ≥44px tap target (padding:16px 24px)npm run check→ "TinyStudio.io checks passed." (exit 0)npm test→ exit 0: headings 6/6, sitemap 7/7, worker 76/76, UI 8/8, contract 16/16, viewport 4/4, narrow-viewport 4/4 owned routesGET https://tinystudio.io/specimen→ HTTP 200, body byte-identical to source (normalized), band CTA present;/specimen.html→ 307 →/specimenFiles
docs/evidence/specimen-in-content-cta-rereverify-2026-08-14.md— re-verification receipt.lane/reports/specimen-in-content-cta-rereverify-2026-08-14.md— lane report